%0 Journal Article
%T Spatially Informed Gene Signatures for Response to Immunotherapy in Melanoma.
%A Aung TN
%A Warrell J
%A Martinez-Morilla S
%A Gavrielatou N
%A Vathiotis I
%A Yaghoobi V
%A Kluger HM
%A Gerstein M
%A Rimm DL
%J Clin Cancer Res
%V 30
%N 16
%D 2024 Aug 15
%M 38837895
%F 13.801
%R 10.1158/1078-0432.CCR-23-3932
%X <B>UNASSIGNED: </B>We aim to improve the prediction of response or resistance to immunotherapies in patients with melanoma. This goal is based on the hypothesis that current gene signatures predicting immunotherapy outcomes show only modest accuracy due to the lack of spatial information about cellular functions and molecular processes within tumors and their microenvironment.<BR><B>UNASSIGNED: </B>We collected gene expression data spatially from three cellular compartments defined by CD68+ macrophages, CD45+ leukocytes, and S100B+ tumor cells in 55 immunotherapy-treated melanoma specimens using Digital Spatial Profiling-Whole Transcriptome Atlas. We developed a computational pipeline to discover compartment-specific gene signatures and determine if adding spatial information can improve patient stratification.<BR><B>UNASSIGNED: </B>We achieved robust performance of compartment-specific signatures in predicting the outcome of immune checkpoint inhibitors in the discovery cohort. Of the three signatures, the S100B signature showed the best performance in the validation cohort (N = 45). We also compared our compartment-specific signatures with published bulk signatures and found the S100B tumor spatial signature outperformed previous signatures. Within the eight-gene S100B signature, five genes (PSMB8, TAX1BP3, NOTCH3, LCP2, and NQO1) with positive coefficients predict the response, and three genes (KMT2C, OVCA2, and MGRN1) with negative coefficients predict the resistance to treatment.<BR><B>UNASSIGNED: </B>We conclude that the spatially defined compartment signatures utilize tumor and tumor microenvironment-specific information, leading to more accurate prediction of treatment outcome, and thus merit prospective clinical assessment.